| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 4 securities · may seek to influence control | ||||||
|
Hyperscale Data, Inc.
13D/A
GPUS · 09175M879
|
64.1% |
10/1/2026
Event 9/30/2026
|
||||
| Ault & Company, Inc. | 63.9% | |||||
| Ault Milton C III | 64.1% | |||||
| Horne William B | 0.4% | |||||
| Nisser Henry Carl | 0.2% | |||||
| Cragun Kenneth S | 0.1% | |||||
|
Hyperscale Data, Inc.
13D/A
09715M804
|
53.3% |
6/12/2026
Event 6/10/2026
|
||||
| Ault & Company, Inc. | 53.2% | |||||
| Ault Milton C III | 53.3% | |||||
| Horne William B | 0.3% | |||||
| Nisser Henry Carl | 0.2% | |||||
| Cragun Kenneth S | 0.1% | |||||
|
Hyperscale Data, Inc.
13D/A
GPUS · 09175M804
|
35.6% |
11/20/2025
Event 11/18/2025
|
||||
| Ault & Company, Inc. | 35.5% | |||||
| Ault Milton C III | 35.6% | |||||
| Horne William B | 0% | |||||
| Nisser Henry Carl | 0% | |||||
| Cragun Kenneth S | 0% | |||||
|
Alzamend Neuro, Inc.
13D/A
ALZN · 02262M605
|
4.4% |
10/7/2025
Event 10/3/2025
|
||||
| Milton C. Ault, III | 4.4% | |||||
| William B. Horne | 0.1% | |||||
| Henry C.W. Nisser | 0% | |||||
| Kenneth S. Cragun | 0% | |||||
| David J. Katzoff | 0% | |||||
| Hyperscale Data, Inc. | 4.0% | |||||
| Ault Lending, LLC | 4.0% | |||||
| Ault Life Sciences, Inc. | 0.3% | |||||
| Ault Life Sciences Fund, LLC | 0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.